These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9672772

  • 21. Non-Hodgkin's lymphoma: the evolving role of purine analogues.
    Zinzani PL.
    Best Pract Res Clin Haematol; 2002 Sep; 15(3):505-16. PubMed ID: 12468402
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE.
    Henry Ford Hosp Med J; 1991 Sep; 39(2):98-102. PubMed ID: 1679757
    [Abstract] [Full Text] [Related]

  • 25. Fludarabine in the management of malignant lymphomas.
    Hiddemann W, Pott-Hoeck C.
    Drugs; 1994 Sep; 47 Suppl 6():50-6. PubMed ID: 7525189
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
    Bergmann L.
    Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
    [Abstract] [Full Text] [Related]

  • 28. [A new purine analog in the treatment of hematologic malignancy. I. Fludarabine].
    Vásová I, Penka M, Hájek R, Mayer J, Krahulcová E.
    Vnitr Lek; 1997 Jan; 43(1):45-50. PubMed ID: 9221567
    [Abstract] [Full Text] [Related]

  • 29. Treatment of hairy-cell leukemia: current views.
    Tallman MS, Peterson LC, Hakimian D, Gillis S, Polliack A.
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [Abstract] [Full Text] [Related]

  • 30. Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma.
    Zinzani PL.
    Hematol J; 2004 Apr; 5 Suppl 1():S38-49. PubMed ID: 15079152
    [Abstract] [Full Text] [Related]

  • 31. Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone.
    Armitage JO, Tobinai K, Hoelzer D, Rummel MJ.
    Int J Hematol; 2004 May; 79(4):311-21. PubMed ID: 15218957
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma.
    Saven A, Lee T, Kosty M, Piro L.
    J Clin Oncol; 1996 Jul; 14(7):2139-44. PubMed ID: 8683247
    [Abstract] [Full Text] [Related]

  • 34. Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.
    Nagai H, Ogura M, Kusumoto S, Takahashi N, Yamaguchi M, Takayama N, Kinoshita T, Motoji T, Ohyashiki K, Kosugi H, Matsuda S, Ohnishi K, Omachi K, Hotta T.
    Eur J Haematol; 2011 Feb; 86(2):117-23. PubMed ID: 21070370
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
    Keating MJ, McLaughlin P, Plunkett W, Robertson LE, O'Brien S, Gandhi V, Gregoire V, Yang L, Cabanillas F.
    Ann Oncol; 1994 Feb; 5 Suppl 2():79-83. PubMed ID: 8204523
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep 18; 34(879):89-90. PubMed ID: 1355592
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.